Health · 3 views
Microbiome therapy shows promise for preventing deadly bloodstream infections in early trial
Researchers at City of Hope and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.
Summary
Researchers at City of Hope and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens. In the multicenter phase 1 clinical trial , scientists from City of Hope, Memorial Sloan Kettering Cancer Center and Seres Therapeutics found that the new therapy, called SER-155, was well tolerated with no treatment-related side effects.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Older women are as varied and individual as we have ever been | LettersContinue reading
- It is time the government treated hunger and obesity as two interlinked problems | LetterContinue reading
- Single iron infusion improved exercise capacity in people with the most common form of heart failureContinue reading
- Tired all the time? What to know about B12 and if it actually boosts energy levelsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow